TrialBMJ open2021

Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO06 trial in osteosarcoma.

Marta Spreafico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.